Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Paragon holds guidance as volumes, margins perform

(Sharecast News) - Paragon Bank confirmed full-year guidance as volumes margins and costs during the third quarter were in line with expectations. The lender and savings provider said new business levels were running ahead of expectations with buy-to-let mortgage application flows strong, resulting in the pipeline increasing slightly during the quarter, at £888.5m, and "significantly higher" than the £594.6m reported last September.

"Growth in development finance enquiry levels reported at the half-year results has continued, with the pipeline up 29% and the value of undrawn commitments remaining at elevated levels during the quarter," it added.

"The new government's focus on developing the scale of new house building also enhances the outlook for this sector. Following the quarter end, the SME division gained accreditation to provide additional lending under the Growth Guarantee Scheme."

Paragon said the combination of new lending levels and strong customer retention has resulted in the net loan book increasing by 5% year-on-year, to £15.4bn.

It also said net interest margin - the difference between savings and loan rates - remained strong and guidance for the full year of more than 310 basis points was reconfirmed.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

Smith & Nephew appoints Ajay Dhankhar as chief corporate development & strategy officer
(Sharecast News) - Medical technology company Smith & Nephew said on Monday that it has appointed Ajay Dhankhar as chief corporate development & strategy officer with immediate effect.
Oxford Biomedica acquires last 10pc stake in US subsidiary
(Sharecast News) - Oxford Biomedica said on Monday it has acquired the remaining 10% stake in its US subsidiary, OXB US, from Q32 Bio, bringing its ownership of the business to 100% as previously planned.
PPHE acquiring prime London site for hotel development
(Sharecast News) - PPHE Hotel Group has announced the acquisition of a prime development site near the City of London, where it plans to build its first Radisson RED select service hotel in the capital.
Norcros to end tile production in South Africa
(Sharecast News) - Norcros announced on Monday that it will shut down manufacturing at Johnson Tiles South Africa at the end of June, following the conclusion of a strategic review.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.